Detection of acquired resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer using circulating tumor DNA
Ontology highlight
ABSTRACT: Primary outcome(s): Association between progression-free survival and the period from the introduction of anti-EGFR antibodies to detect genetic changes in circulating tumor DNA
DISEASE(S): Colorectal Cancer
PROVIDER: 2649995 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA